Internal Medicine, Critical Care Medicine · Denver, CO
NPI
1962840934
Since 2013
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1400 Jackson St
Denver, CO, 80206
Phone (303) 388-4461
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
147 services
Medicare patients, 2024
92
Average age 73
Drug cost, 2024
$787K
439 prescriptions
Company payments, 2025
$1,091
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick S Hume was code 99215 (office e&m - established), 74 times for 59 patients. In total Patrick S Hume billed 147 services in 4 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 74 | 59 | $109.08 | $8,072 |
| 99205 Office E&M - New | Facility | 31 | 31 | $145.37 | $4,506 |
| 99214 Office E&M - Established | Facility | 22 | 21 | $75.46 | $1,660 |
By year: 2022 $15K for 131 services; 2023 $6,513 for 63 services; 2024 $15K for 147 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patrick S Hume prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 84 prescriptions and refills. In total Patrick S Hume wrote 439 Medicare prescriptions that cost $787K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 84 | 130 | 20 | $80K |
| Prolastin C Alpha-1-Proteinase Inhibitor | 50 | 50 | Under 11 | $614K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 40 | 47 | 18 | $674 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 39 | 63 | Under 11 | $28K |
| Prednisone Generic | 30 | 36 | 16 | $64.45 |
| Roflumilast Generic | 25 | 45 | Under 11 | $2,850 |
| Azithromycin Generic | 24 | 44 | 12 | $666 |
| Omeprazole Generic | 17 | 23 | Under 11 | $240 |
| Spiriva Respimat Tiotropium Bromide | 15 | 15 | Under 11 | $8,136 |
| Breo Ellipta Fluticasone/Vilanterol | 14 | 14 | Under 11 | $5,762 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 13 | 21 | Under 11 | $9,932 |
Brand drugs: 296 claims; generic drugs: 143 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick S Hume $1,091 ($1,091 in general payments such as food, travel and fees) from 2 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $984.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.